New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
June 15, 2020 - Eli Lilly announced the FDA approval of Lyumjev (insulin lispro-aabc), to improve glycemic control in adults with diabetes mellitus.
Download PDF
Return to publications
